Revitope Oncology's Unattributed Round

Revitope Oncology raised a round of funding on February 08, 2016.

Revitope Oncology is a cancer immunotherapy company developing a platform based on redirecting viral immunity for the purpose of developing compounds to treat solid tumors and hematologic malignancies…

Articles about Revitope Oncology's Unattributed Round: